Browse by Research Team

Article

Cross-recognition of a myelin peptide by CD8(+) T cells in the CNS is not sufficient to promote neuronal damage.
Reuter, E., Gollan, R., Grohmann, N., Paterka, M., Salmon, H., Birkenstock, J., Richers, S., Leuenberger, T., Brandt, A.U., Kuhlmann, T., Zipp, F. and Siffrin, V.
Journal of Neuroscience 35 (12): 4837-4850. 25 March 2015

Modulation of dendritic cell immunobiology via inhibition of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase.
Leuenberger, T., Pfueller, C.F., Luessi, F., Bendix, I., Paterka, M., Prozorovski, T., Treue, D., Luenstedt, S., Herz, J., Siffrin, V., Infante-Duarte, C., Zipp, F. and Waiczies, S.
PLoS ONE 9 (7): e100871. 11 July 2014

The role of CD8(+) T cells and their local interaction with CD4(+) T cells in myelin oligodendrocyte glycoprotein(35-55)-induced experimental autoimmune encephalomyelitis.
Leuenberger, T., Paterka, M., Reuter, E., Herz, J., Niesner, R.A., Radbruch, H., Bopp, T., Zipp, F. and Siffrin, V.
Journal of Immunology 191 (10): 4960-4968. 15 November 2013

A "candidate-interactome" aggregate analysis of genome-wide association data in multiple sclerosis.
Mechelli, R., Umeton, R., Policano, C., Annibali, V., Coarelli, G., Ricigliano, V.A.G., Vittori, D., Fornasiero, A., Buscarinu, M.C., Romano, S., Salvetti, M. and Ristori, G.
PLoS ONE 8 (5): e63300. 16 May 2013

Parallelized TCSPC for dynamic intravital fluorescence lifetime imaging: quantifying neuronal dysfunction in neuroinflammation.
Rinnenthal, J.L., Börnchen, C., Radbruch, H., Andresen, V., Mossakowski, A., Siffrin, V., Seelemann, T., Spiecker, H., Moll, I., Herz, J., Hauser, A.E., Zipp, F., Behne, M.J. and Niesner, R.
PLoS ONE 8 (4): e60100. 16 April 2013

In vivo imaging of lymphocytes in the CNS reveals different behaviour of naive T cells in health and autoimmunity.
Herz, J., Paterka, M., Niesner, R.A., Brandt, A.U., Siffrin, V., Leuenberger, T., Birkenstock, J., Mossakowski, A., Glumm, R., Zipp, F. and Radbruch, H.
Journal of Neuroinflammation 8 (1): 131. 6 October 2011

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.
Sawcer, S., Hellenthal, G., Pirinen, M., Spencer, C.C., Patsopoulos, N.A., Moutsianas, L., Dilthey, A., Su, Z., Freeman, C., Hunt, S.E., Edkins, S., Gray, E., Booth, D.R., Potter, S.C., Goris, A., Band, G., Oturai, A.B., Strange, A., Saarela, J., Bellenguez, C., Fontaine, B., Gillman, M., Hemmer, B., Gwilliam, R., Zipp, F., Jayakumar, A., Martin, R., Leslie, S., Hawkins, S., Giannoulatou, E., D'alfonso, S., Blackburn, H., Boneschi, F.M., Liddle, J., Harbo, H.F., Perez, M.L., Spurkland, A., Waller, M.J., Mycko, M.P., Ricketts, M., Comabella, M., Hammond, N., Kockum, I., McCann, O.T., Ban, M., Whittaker, P., Kemppinen, A., Weston, P., Hawkins, C., Widaa, S., Zajicek, J., Dronov, S., Robertson, N., Bumpstead, S.J., Barcellos, L.F., Ravindrarajah, R., Abraham, R., Alfredsson, L., Ardlie, K., Aubin, C., Baker, A., Baker, K., Baranzini, S.E., Bergamaschi, L., Bergamaschi, R., Bernstein, A., Berthele, A., Boggild, M., Bradfield, J.P., Brassat, D., Broadley, S.A., Buck, D., Butzkueven, H., Capra, R., Carroll, W.M., Cavalla, P., Celius, E.G., Cepok, S., Chiavacci, R., Clerget-Darpoux, F., Clysters, K., Comi, G., Cossburn, M., Cournu-Rebeix, I., Cox, M.B., Cozen, W., Cree, B.A., Cross, A.H., Cusi, D., Daly, M.J., Davis, E., de Bakker, P.I., Debouverie, M., D'hooghe, M.B., Dixon, K., Dobosi, R., Dubois, B., Ellinghaus, D., Elovaara, I., Esposito, F., Fontenille, C., Foote, S., Franke, A., Galimberti, D., Ghezzi, A., Glessner, J., Gomez, R., Gout, O., Graham, C., Grant, S.F., Guerini, F.R., Hakonarson, H., Hall, P., Hamsten, A., Hartung, H.P., Heard, R.N., Heath, S., Hobart, J., Hoshi, M., Infante-Duarte, C., Ingram, G., Ingram, W., Islam, T., Jagodic, M., Kabesch, M., Kermode, A.G., Kilpatrick, T.J., Kim, C., Klopp, N., Koivisto, K., Larsson, M., Lathrop, M., Lechner-Scott, J.S., Leone, M.A., Leppa, V., Liljedahl, U., Bomfim, I.L., Lincoln, R.R., Link, J., Liu, J., Lorentzen, A.R., Lupoli, S., Macciardi, F., Mack, T., Marriott, M., Martinelli, V., Mason, D., McCauley, J.L., Mentch, F., Mero, I.L., Mihalova, T., Montalban, X., Mottershead, J., Myhr, K.M., Naldi, P., Ollier, W., Page, A., Palotie, A., Pelletier, J., Piccio, L., Pickersgill, T., Piehl, F., Pobywajlo, S., Quach, H.L., Ramsay, P.P., Reunanen, M., Reynolds, R., Rioux, J.D., Rodegher, M., Roesner, S., Rubio, J.P., Ruckert, I.M., Salvetti, M., Salvi, E., Santaniello, A., Schaefer, C.A., Schreiber, S., Schulze, C., Scott, R.J., Sellebjerg, F., Selmaj, K.W., Sexton, D., Shen, L., Simms-Acuna, B., Skidmore, S., Sleiman, P.M., Smestad, C., Sorensen, P.S., Sondergaard, H.B., Stankovich, J., Strange, R.C., Sulonen, A.M., Sundqvist, E., Syvanen, A.C., Taddeo, F., Taylor, B., Blackwell, J.M., Tienari, P., Bramon, E., Tourbah, A., Brown, M.A., Tronczynska, E., Casas, J.P., Tubridy, N., Corvin, A., Vickery, J., Jankowski, J., Villoslada, P., Markus, H.S., Wang, K., Mathew, C.G., Wason, J., Palmer, C.N., Wichmann, H.E., Plomin, R., Willoughby, E., Rautanen, A., Winkelmann, J., Wittig, M., Trembath, R.C., Yaouanq, J., Viswanathan, A.C., Zhang, H., Wood, N.W., Zuvich, R., Deloukas, P., Langford, C., Duncanson, A., Oksenberg, J.R., Pericak-Vance, M.A., Haines, J.L., Olsson, T., Hillert, J., Ivinson, A.J., De Jager, P.L., Peltonen, L., Stewart, G.J., Hafler, D.A., Hauser, S.L., McVean, G., Donnelly, P. and Compston, A.
Nature 476 (7359): 214-219. 10 August 2011

Patterns of retinal nerve fiber layer loss in multiple sclerosis patients with or without optic neuritis and glaucoma patients.
Bock, M., Brandt, A.U., Doerr, J., Kraft, H., Weinges-Evers, N., Gaede, G., Pfueller, C.F., Herges, K., Radbruch, H., Ohlraun, S., Bellmann-Strobl, J., Kuchenbecker, J., Zipp, F. and Paul, F.
Clinical Neurology and Neurosurgery 112 (8): 647-652. October 2010

In vivo imaging of partially reversible th17 cell-induced neuronal dysfunction in the course of encephalomyelitis.
Siffrin, V., Radbruch, H., Glumm, R., Niesner, R., Paterka, M., Herz, J., Leuenberger, T., Lehmann, S.M., Luenstedt, S., Rinnenthal, J.L., Laube, G., Luche, H., Lehnardt, S., Fehling, H.J., Griesbeck, O. and Zipp, F.
Immunity 33 (3): 424-436. 24 September 2010

Correlation of self-assessed fatigue and alertness in multiple sclerosis.
Weinges-Evers, N., Brandt, A.U., Bock, M., Pfueller, C.F., Doerr, J., Bellmann-Strobl, J., Scherer, P., Urbanek, C., Boers, C., Ohlraun, S., Zipp, F. and Paul, F.
Multiple Sclerosis 16 (9): 1134-1140. September 2010

MAPK3 deficiency drives autoimmunity via dendritic cell arming.
Bendix, I., Pfueller, C.F., Leuenberger, T., Glezeva, N., Siffrin, V., Mueller, Y., Prozorovski, T., Hansen, W., Schulze-Topphoff, U., Loddenkemper, C., Zipp, F. and Waiczies, S.
European Journal of Immunology 40 (5): 1486-1495. May 2010

No significant effect of orally administered chemokine receptor 1 antagonist on intercellular adhesion molecule-3 expression in relapsing--remitting multiple sclerosis patients.
Reuss, R., Schreiber, V., Klein, A., Infante-Duarte, C., Filippi, M., Pabst, W., Pohl, C. and Oschmann, P.
Multiple Sclerosis 16 (3): 366-369. March 2010

Expanding two-photon intravital microscopy to the infrared by means of optical parametric oscillator.
Herz, J., Siffrin, V., Hauser, A.E., Brandt, A.U., Leuenberger, T., Radbruch, H., Zipp, F. and Niesner, R.A.
Biophysical Journal 98 (4): 715-723. 17 February 2010

MR-elastography reveals degradation of tissue integrity in multiple sclerosis.
Wuerfel, J., Paul, F., Beierbach, B., Hamhaber, U., Klatt, D., Papazoglou, S., Zipp, F., Martus, P., Braun, J. and Sack, I.
NeuroImage 49 (3): 2520-2525. 1 February 2010

Dysregulated Epstein-Barr virus infection in patients with CIDP.
Luenemann, J.D., Tackenberg, B., Stein, A., Wandinger, K.P., Oertel, W.H., Wagner, H.J., Muenz, C., Meisel, H., Sommer, N. and Zipp, F.
Journal of Neuroimmunology 218 (1-2): 107-111. 25 January 2010

Attention Network Test reveals alerting network dysfunction in multiple sclerosis.
Urbanek, C., Weinges-Evers, N., Bellmann-Strobl, J., Bock, M., Doerr, J., Hahn, E., Neuhaus, A.H., Opgen-Rhein, C., Ta, T.M., Herges, K., Pfueller, C.F., Radbruch, H., Wernecke, K.D., Ohlraun, S., Zipp, F., Dettling, M. and Paul, F.
Multiple Sclerosis 16 (1): 93-99. January 2010

Cytotoxic CD8+ T cell-neuron interactions: perforin-dependent electrical silencing precedes but is not causally linked to neuronal cell death.
Meuth, S.G., Herrmann, A.M., Simon, O.J., Siffrin, V., Melzer, N., Bittner, S., Meuth, P., Langer, H.F., Hallermann, S., Boldakowa, N., Herz, J., Munsch, T., Landgraf, P., Aktas, O., Heckmann, M., Lessmann, V., Budde, T., Kieseier, B.C., Zipp, F. and Wiendl, H.
Journal of Neuroscience 29 (49): 15397-15409. 9 December 2009

Bilateral stroke following pituitary apoplexy.
Lill, C.M., Hoch, H., Dieste, F.J., Vogel, H.P., Zipp, F. and Paul, F.
Journal of Clinical Neuroscience 16 (12): 1670-1673. December 2009

Encephalopathy, visual disturbance and hearing loss-recognizing the symptoms of Susac syndrome.
Doerr, J., Radbruch, H., Bock, M., Wuerfel, J., Brueggemann, A., Wandinger, K.P., Zeise, D., Pfueller, C.F., Zipp, F. and Paul, F.
Nature Reviews Neurology 5 (12): 683-688. December 2009

Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis.
Bellmann-Strobl, J., Wuerfel, J., Aktas, O., Doerr, J., Wernecke, K.D., Zipp, F. and Paul, F.
Neurology 73 (20): 1624-1627. 17 November 2009

ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
Cotte, S., von Ahsen, N., Kruse, N., Huber, B., Winkelmann, A., Zettl, U.K., Starck, M., Koenig, N., Tellez, N., Doerr, J., Paul, F., Zipp, F., Luehder, F., Koepsell, H., Pannek, H., Montalban, X., Gold, R. and Chan, A.
Brain 132 (Pt 9): 2517-2530. September 2009

Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.
Vogt, J., Paul, F.E., Aktas, O., Mueller-Wielsch, K., Doerr, J., Doerr, S., Bharathi, B.S., Glumm, R., Schmitz, C., Steinbusch, H., Raine, C.S., Tsokos, M., Nitsch, R. and Zipp, F.
Annals of Neurology 66 (3): 310-322. September 2009

Beyond blood brain barrier breakdown - in vivo detection of occult neuroinflammatory foci by magnetic nanoparticles in high field MRI.
Tysiak, E., Asbach, P., Aktas, O., Waiczies, H., Smyth, M., Schnorr, J., Taupitz, M. and Wuerfel, J.
Journal of Neuroinflammation 6 (1): 20. 6 August 2009

MR spectroscopy (MRS) and magnetisation transfer imaging (MTI), lesion load and clinical scores in early relapsing remitting multiple sclerosis: a combined cross-sectional and longitudinal study.
Bellmann-Strobl, J., Stiepani, H., Wuerfel, J., Bohner, G., Paul, F., Warmuth, C., Aktas, O., Wandinger, K.P., Zipp, F. and Klingebiel, R.
European Radiology 19 (8): 2066-2074. August 2009

Activation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous system.
Schulze-Topphoff, U., Prat, A., Prozorovski, T., Siffrin, V., Paterka, M., Herz, J., Bendix, I., Ifergan, I., Schadock, I., Mori, M.A., Van Horssen, J., Schroeter, F., Smorodchenko, A., Han, M.H., Bader, M., Steinman, L., Aktas, O. and Zipp, F.
Nature Medicine 15 (7): 788-793. July 2009

Targeting activated microglia in Alzheimer's pathology by intraventricular delivery of a phagocytosable MRI contrast agent in APP23 transgenic mice.
Mundt, A.P., Winter, C., Mueller, S., Wuerfel, J., Tysiak, E., Schnorr, J., Taupitz, M., Heinz, A. and Juckel, G.
NeuroImage 46 (2): 367-372. June 2009

Differential immune cell dynamics in the CNS cause CD4+ T cell compartmentalization.
Siffrin, V., Brandt, A.U., Radbruch, H., Herz, J., Boldakowa, N., Leuenberger, T., Werr, J., Hahner, A., Schulze-Topphoff, U., Nitsch, R. and Zipp, F.
Brain 132 (5): 1247-1258. May 2009

United Europeans for development of pharmacogenomics in multiple sclerosis network.
Vandenbroeck, K., Comabella, M., Tolosa, E., Goertsches, R., Brassat, D., Hintzen, R., Infante-Duarte, C., Favorov, A., Escorza, S., Palacios, R., Oksenberg, J.R. and Villoslada, P.
Pharmacogenomics 10 (5): 885-894. May 2009

Neuroprotection and enhanced neurogenesis by extract from the tropical plant Knema laurina after inflammatory damage in living brain tissue.
Haeke, I., Schoenenberger, S., Neumann, J., Franke, K., Paulsen-Merker, K., Reymann, K., Ismail, G., Bin Din, L., Said, I.M., Latiff, A., Wessjohann, L., Zipp, F. and Ullrich, O.
Journal of Neuroimmunology 206 (1-2): 91-99. 3 January 2009

Therapeutic targeting of chemokine signaling in Multiple Sclerosis.
Hamann, I., Zipp, F. and Infante-Duarte, C.
Journal of the Neurological Sciences 274 (1-2): 31-38. 15 November 2008

Perivascular spaces - MRI marker of inflammatory activity in the brain?
Wuerfel, J., Haertle, M., Waiczies, H., Tysiak, E., Bechmann, I., Wernecke, K.D., Zipp, F. and Paul, F.
Brain 131 (Pt 9): 2332-2340. September 2008

Autoregulation of Th1-mediated inflammation by twist1.
Niesner, U., Albrecht, I., Janke, M., Doebis, C., Loddenkemper, C., Lexberg, M.H., Eulenburg, K., Kreher, S., Koeck, J., Baumgrass, R., Bonhagen, K., Kamradt, T., Enghard, P., Humrich, J.Y., Rutz, S., Schulze-Topphoff, U., Aktas, O., Bartfeld, S., Radbruch, H., Hegazy, A.N., Lohning, M., Baumgart, D.C., Duchmann, R., Rudwaleit, M., Haupl, T., Gitelman, I., Krenn, V., Gruen, J., Sieper, J., Zeitz, M., Wiedenmann, B., Zipp, F., Hamann, A., Janitz, M., Scheffold, A., Burmester, G.R., Chang, H.D. and Radbruch, A.
Journal of Experimental Medicine 205 (8): 1889-1901. 4 August 2008

Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis.
Paul, F., Waiczies, S., Wuerfel, J., Bellmann-Strobl, J., Doerr, J., Waiczies, H., Haertle, M., Wernecke, K.D., Volk, H.D., Aktas, O. and Zipp, F.
PLoS ONE 3 (4): e1928. 9 April 2008

Sirt1 contributes critically to the redox-dependent fate of neural progenitors.
Prozorovski, T., Schulze-Topphoff, U., Glumm, R., Baumgart, J., Schroeter, F., Ninnemann, O., Siegert, E., Bendix, I., Bruestle, O., Nitsch, R., Zipp, F. and Aktas, O.
Nature Cell Biology 10 (4): 385-394. April 2008

Treatment-resistant chronic headaches and focal pachymeningitis in a 46-year-old man: a rare presentation of Wegener's granulomatosis.
Doerr, J., Elitok, S., Dieste, F.J., Vogel, H.P., Schneider, W., Wuerfel, J., Zipp, F. and Paul, F.
Lancet Neurology 7 (4): 368-372. April 2008

Geranylgeranylation but not GTP-loading of Rho GTPases determines T cell function.
Waiczies, S., Bendix, I. and Zipp, F.
Science Signaling 1 (12): pt3. 25 March 2008

Roles of the kallikrein/kinin system in the adaptive immune system.
Schulze-Topphoff, U., Prat, A., Bader, M., Zipp, F. and Aktas, O.
International Immunopharmacology 8 (2): 155-160. February 2008

Neural cell adhesion molecule polysialylation enhances the sensitivity of embryonic stem cell-derived neural precursors to migration guidance cues.
Glaser, T., Brose, C., Franceschini, I., Hamann, K., Smorodchenko, A., Zipp, F., Dubois-Dalcq, M. and Bruestle, O.
Stem Cells 25 (12): 3016-3025. December 2007

Geranylgeranylation but not GTP loading determines rho migratory function in T cells.
Waiczies, S., Bendix, I., Prozorovski, T., Ratner, M., Nazarenko, I., Pfueller, C.F., Brandt, A.U., Herz, J., Brocke, S., Ullrich, O. and Zipp, F.
Journal of Immunology 179 (9): 6024-6032. 1 November 2007

CNS-irrelevant T-cells enter the brain, cause blood-brain barrier disruption but no glial pathology.
Smorodchenko, A., Wuerfel, J., Pohl, E.E., Vogt, J., Tysiak, E., Glumm, R., Hendrix, S., Nitsch, R., Zipp, F. and Infante-Duarte, C.
European Journal of Neuroscience 26 (6): 1387-1398. September 2007

Perioperative fluctuations of lamotrigine serum levels in patients undergoing epilepsy surgery.
Paul, F., Veauthier, C., Fritz, G., Lehmann, T.N., Aktas, O., Zipp, F. and Meencke, H.J.
Seizure 16 (6): 479-484. September 2007

Cerebral blood perfusion changes in multiple sclerosis.
Wuerfel, J., Paul, F. and Zipp, F.
Journal of the Neurological Sciences 259 (1-2): 16-20. 15 August 2007

Development of ulcerative colitis in a patient with multiple sclerosis following treatment with interferon beta 1a.
Schott, E., Paul, F., Wuerfel, J.T., Zipp, F., Rudolph, B., Wiedenmann, B. and Baumgart, D.C.
World Journal of Gastroenterology 13 (26): 3638-3640. 14 July 2007

TRAIL limits excessive host immune responses in bacterial meningitis.
Hoffmann, O., Priller, J., Prozorovski, T., Schulze-Topphoff, U., Baeva, N., Lunemann, J.D., Aktas, O., Mahrhofer, C., Stricker, S., Zipp, F. and Weber, J.R.
Journal of Clinical Investigation 117 (7): 2004-2013. 2 July 2007

Guillain-Barre-Syndrome: current aspects of pathogenesis, diagnosis, and therapy.
Doerr, J. and Zipp, F.
Nervenheilkunde 26 (7): 560-566. July 2007

Mouse model mimics multiple sclerosis in the clinico-radiological paradox.
Wuerfel, J., Tysiak, E., Prozorovski, T., Smyth, M., Mueller, S., Schnorr, J., Taupitz, M. and Zipp, F.
European Journal of Neuroscience 26 (1): 190-198. July 2007

Myasthenia gravis - Aktuelle Aspekte der Pathogenese, Diagnostik und Therapie [Myasthenia gravis: current aspects of pathogenesis, diagnosis, and therapy].
Doerr, J. and Zipp, F.
Nervenheilkunde 26 (7): 587-595. July 2007

The role of TRAIL/TRAIL receptors in central nervous system pathology.
Aktas, O., Schulze-Topphoff, U. and Zipp, F.
Frontiers in Bioscience 12 : 2912-2921. 1 May 2007

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
Paul, F., Jarius, S., Aktas, O., Bluthner, M., Bauer, O., Appelhans, H., Franciotta, D., Bergamaschi, R., Littleton, E., Palace, J., Seelig, H.P., Hohlfeld, R., Vincent, A. and Zipp, F.
PLoS Medicine 4 (4): e133. April 2007

Tolerogenic effect of fiber tract injury: reduced EAE severity following entorhinal cortex lesion.
Mutlu, L., Brandt, C., Kwidzinski, E., Sawitzki, B., Gimsa, U., Mahlo, J., Aktas, O., Nitsch, R., van Zwam, M., Laman, J.D. and Bechmann, I.
Experimental Brain Research 178 (4): 542-553. April 2007

High-field diffusion tensor imaging of mouse brain in vivo using single-shot STEAM MRI.
Boretius, S., Wuerfel, J., Zipp, F., Frahm, J. and Michaelis, T.
Journal of Neuroscience Methods 161 (1): 112-117. 30 March 2007

Neuronal damage in brain inflammation.
Aktas, O., Ullrich, O., Infante-Duarte, C., Nitsch, R. and Zipp, F.
Archives of Neurology 64 (2): 185-189. February 2007

Familial effects on the clinical course of multiple sclerosis.
Hensiek, A.E., Seaman, S.R., Barcellos, L.F., Oturai, A., Eraksoi, M., Cocco, E., Vecsei, L., Stewart, G., Dubois, B., Bellman-Strobl, J., Leone, M., Andersen, O., Bencsik, K., Booth, D., Celius, E.G., Harbo, H.F., Hauser, S.L., Heard, R., Hillert, J., Myhr, K.M., Marrosu, M.G., Oksenberg, J.R., Rajda, C., Sawcer, S.J., Sorensen, P.S., Zipp, F. and Compston, D.A.S.
Neurology 68 (5): 376-383. 30 January 2007

Serum levels of soluble CD95 are not associated with amelioration of multiple sclerosis during pregnancy.
Ehrlich, S., Haas, J., Zipp, F. and Infante-Duarte, C.
Journal of the Neurological Sciences 252 (1): 83-87. January 2007

Blockade of chemokine signaling in patients with multiple sclerosis.
Zipp, F., Hartung, H.P., Hillert, J., Schimrigk, S., Trebst, C., Stangel, M., Infante-Duarte, C., Jakobs, P., Wolf, C., Sandbrink, R., Pohl, C. and Filippi, M.
Neurology 67 (10): 1880-1883. 28 November 2006

Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL.
Aktas, O., Smorodchenko, A., Brocke, S., Infante-Duarte, C., Schulze Topphoff, U., Vogt, J., Prozorovski, T., Meier, S., Osmanova, V., Pohl, E., Bechmann, I., Nitsch, R. and Zipp, F.
Neuron 46 (3): 421-432. 5 May 2005

Conference or Workshop Item

A new light source for multimodal multiphoton microscopy including CARS.
Rimke, I., Siffrin, V., Niesner, R., Leuenberger, T., Zipp, F., Buttnera, E. and Stibenza, G.
In: Conference on Multiphoton Microscopy in the Biomedical Sciences IX, JAN 25-27, 2009 , San Jose, CA, USA. 13 February 2009

Review

Neurodegeneration in autoimmune CNS inflammation.
Herz, J., Zipp, F. and Siffrin, V.
Experimental Neurology 225 (1): 9-17. September 2010

Multiple sclerosis - candidate mechanisms underlying CNS atrophy.
Siffrin, V., Vogt, J., Radbruch, H., Nitsch, R. and Zipp, F.
Trends in Neurosciences 33 (4): 202-210. April 2010

Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammation.
Hoffmann, O., Zipp, F. and Weber, J.R.
Journal of Molecular Medicine 87 (8): 753-763. August 2009

New developments in understanding and treating neuroinflammation.
Infante-Duarte, C., Waiczies, S., Wuerfel, J. and Zipp, F.
Journal of Molecular Medicine 86 (9): 975-985. September 2008

Neues zu Pathogenese, Diagnostik und Therapie der Neuromyelitis optica [Recent findings in pathogenesis, diagnostics and therapy of neuromyelitis optica].
Paul, F., Jarius, S., Glumm, R., Wildemann, B., Zipp, F. and Aktas, O.
Deutsche Medizinische Wochenschrift 133 (21): 1125-1129. May 2008

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
Jarius, S., Paul, F., Franciotta, D., Waters, P., Zipp, F., Hohlfeld, R., Vincent, A. and Wildemann, B.
Nature Clinical Practice Neurology 4 (4): 202-214. April 2008

Impact of HMG-CoA reductase inhibition on brain pathology.
Zipp, F., Waiczies, S., Aktas, O., Neuhaus, O., Hemmer, B., Schraven, B., Nitsch, R. and Hartung, H.P.
Trends in Pharmacological Sciences 28 (7): 342-349. July 2007

Classifications and treatment responses in chronic immune-mediated demyelinating polyneuropathy.
Tackenberg, B., Luenemann, J.D., Steinbrecher, A., Rothenfusser-Korber, E., Sailer, M., Brueck, W., Schock, S., Zschenderlein, R., Zipp, F. and Sommer, N.
Neurology 68 (19): 1622-1629. 8 May 2007

Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targets.
Aktas, O., Waiczies, S. and Zipp, F.
Journal of Neuroimmunology 184 (1-2): 17-26. March 2007

New insights into adaptive immunity in chronic neuroinflammation.
Siffrin, V., Brandt, A.U., Herz, J. and Zipp, F.
Advances in Immunology 96 : 1-40. 2007

The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases.
Zipp, F. and Aktas, O.
Trends in Neurosciences 29 (9): 518-527. September 2006

Letter

Multiple sclerosis following etanercept treatment for ankylosing spondylitis.
Pfueller, C.F., Seipelt, E., Zipp, F. and Paul, F.
Scandinavian Journal of Rheumatology 37 (5): 397-399. September 2008

Early mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis.
Paul, F., Doerr, J., Wuerfel, J., Vogel, H.P. and Zipp, F.
Journal of Neurology Neurosurgery and Psychiatry 78 (2): 198-200. February 2007

Editorial

A woman with acute myelopathy in pregnancy: case outcome.
Reuss, R., Rommer, P.S., Brueck, W., Paul, F., Bolz, M., Jarius, S., Boettcher, T., Grossmann, A., Bock, A., Zipp, F., Benecke, R. and Zettl, U.K.
British Medical Journal 339 : b4026. 10 December 2009

A woman with acute myelopathy in pregnancy: case progression.
Reuss, R., Rommer, P.S., Brueck, W., Paul, F., Bolz, M., Jarius, S., Boettcher, T., Grossmann, A., Bock, A., Zipp, F., Benecke, R. and Zettl, U.K.
British Medical Journal 339 : b4025. 19 November 2009

A woman with acute myelopathy in pregnancy: case presentation.
Reuss, R., Rommer, P.S., Brueck, W., Paul, F., Bolz, M., Jarius, S., Boettcher, T., Grossmann, A., Bock, A., Zipp, F., Benecke, R. and Zettl, U.K.
British Medical Journal 339 : b3862. 12 November 2009

Neuromyelitis and more: the unfolding spectrum of aquaporin 4-related neurological diseases.
Aktas, O. and Hartung, H.P.
Journal of Neurology 256 (11): 1906-1908. November 2009

Severe cardiac failure in a patient with multiple sclerosis following low-dose mitoxantrone treatment.
Doerr, J., Bitsch, A., Schmailzl, K.J., Chan, A., von Ahsen, N., Hummel, M., Varon, R., Lill, C.M., Vogel, H.P., Zipp, F. and Paul, F.
Neurology 73 (12): 991-993. 22 September 2009

Celiac antibodies in the diagnostic workup of white matter lesions.
Paul, F., Pfueller, C.F., Wuerfel, J.T., Egerer, K., Tanczos, B., Baumgart, D.C. and Zipp, F.
Neurology 71 (3): 223-225. 15 July 2008

Revised diagnostic criteria for neuromyelitis optica - incorporation of NMO-IgG status.
Jarius, S., Paul, F., Franciotta, D., Aktas, O., Hohlfeld, R., Zipp, F. and Vincent, A.
Nature Clinical Practice Neurology 3 (5): E1. May 2007

Special issue on inflammation, neurodegeneration and neuroprotection in the central nervous system - Introduction.
Zipp, F. and Trapp, B.D.
Journal of Neuroimmunology 184 (1-2): 1-3. March 2007